Evaluation of Boldine Activity against Intracellular Amastigotes of Leishmania amazonensis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Leishmaniasis is a neglected and endemic disease that affects poorest population mainly in developing countries. A lack of adequate and definitive chemotherapeutic agents to fight against this infection has led to the investigation of numerous compounds. The aim of this study was to investigate in vitro activity of boldine against Leishmania amazonensis murine cell infection. Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) is an aporphine alkaloid found abundantly in the leaves/bark of boldo (Peumus boldus Molina), a widely distributed tree native to Chile. The in vitro system consisted of murine macrophage infection with amastigotes of L. amazonensis treated with different concentrations from 50 to 600 μg/ml of boldine for 24 hr. Intracellular parasite destruction was assessed by morphological examination and boldine cytotoxicity to macrophages was tested by the MTT viability assay. When cells were treated with 100 μg/ml of boldine the reduction of parasite infection was 81% compared with untreated cultures cells. Interestingly, boldine-treatment caused a concentration-dependent decrease of macrophage infection that culminated with 96% of reduction when cells were submitted to 600 μg/ml of boldine. Cell cultures exposed to 100 μg/ml of boldine and 300 μg/ml of Glucantime® during 24 hr showed a significant reduction of 50% in parasitized cells compared with cell cultures exposed just to Glucantime®. The study showed that treatment with boldine produces a better effect than treatment with the reference antimonial drug, glucantime, in L. amazonensis infected macrophage. Our results suggest that boldine is a potentially useful agent for the treatment of leishmaniasis.
Abstract
Leishmaniasis is a neglected and endemic disease that affects poorest population mainly in developing countries. A lack of adequate and definitive chemotherapeutic agents to fight against this infection has led to the investigation of numerous compounds. The aim of this study was to investigate in vitro activity of boldine against Leishmania amazonensis murine cell infection. Boldine ((S)-2,9-dihydroxy-1,10-dimethoxy-aporphine) is an aporphine alkaloid found abundantly in the leaves/bark of boldo (Peumus boldus Molina), a widely distributed tree native to Chile. The in vitro system consisted of murine macrophage infection with amastigotes of L. amazonensis treated with different concentrations from 50 to 600 μg/ml of boldine for 24 hr. Intracellular parasite destruction was assessed by morphological examination and boldine cytotoxicity to macrophages was tested by the MTT viability assay. When cells were treated with 100 μg/ml of boldine the reduction of parasite infection was 81% compared with untreated cultures cells. Interestingly, boldine-treatment caused a concentration-dependent decrease of macrophage infection that culminated with 96% of reduction when cells were submitted to 600 μg/ml of boldine. Cell cultures exposed to 100 μg/ml of boldine and 300 μg/ml of Glucantime® during 24 hr showed a significant reduction of 50% in parasitized cells compared with cell cultures exposed just to Glucantime®. The study showed that treatment with boldine produces a better effect than treatment with the reference antimonial drug, glucantime, in L. amazonensis infected macrophage. Our results suggest that boldine is a potentially useful agent for the treatment of leishmaniasis.
참고문헌 (28)
- Grimaldi G Jr, "Leishmaniasis of the New World : current concepts and implications for future research", Clin Microbiol Rev, 6, pp.230~250 (1993)
- Alvar J, "Leishmaniasis worldwide and global estimates of its incidence", PLoS One, 7, pp.e35671~ (2012)
- Frézard F, "Pentavalent antimonials : new perspectives for old drugs", Molecules, 14, pp.2317~2336 (2009)
- Sundar S, "Oral miltefosine for Indian visceral leishmaniasis", N Engl J Med, 347, pp.1739~1746 (2002)
- Kedzierski L, "Early CD44hiCD4+ and CD44hiCD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity", Parasitology, 136, pp.833~840 (2003)
- Murray HW, "Progress in the treatment of a neglected infectious disease : visceral leishmaniasis", Expert Rev Anti Infect Ther, 2, pp.279~292 (2004)
- Brito AM, "Plants with anti-Leishmania activity : Integrative review from 2000 to 2011", Pharmacogn Rev, 7, pp.34~41 (2013)
- Saklani A, "Plant-derived compounds in clinical trials", Drug Discov Today, 13, pp.161~171 (2008)
- Trouiller P, "Drug development for neglected diseases : a deficient market and a public health policy failure", Lancet, 359, pp.2188~2194 (2002)
- Eissa MM, "Leishmania major : activity of tamoxifen against experimental cutaneous leishmaniasis", Exp Parasitol, 128, pp.382~390 (2011)
- Trinconi CT, "Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis", Antimicrob Agents Chemother, 58, pp.2608~2613 (2014)
- Mukhtar MR, "Grandine A, a new proaporphine alkaloid from the bark of Phoebe grandis", Molecules, 23, pp.1227~1233 (2009)
- O’Brien P, "Boldine and its antioxidant or health-promoting properties", Chem Biol Interact, 159, pp.1~17 (2006)
- Lau YS, "Boldine protects endothelial function in hyperglycemia-induced oxidative stress through an antioxidant mechanism", Biochem Pharmacol, 85, pp.367~375 (2013)
- Liew FY, "Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine", Immunology, 71, pp.556~559 (1990)
- Barbieri CL, "Glycosphingolipid antigens of Leishmania(Leishmania)amazonensis amastigotes identified by use of a monoclonal antibody", Infect Immun, 61, pp.2131~2137 (1993)
- Giorgio S, "In vivo formation of electron paramagnetic resonance-detectable nitric oxide and nitrotyrosine is not impaired during murine leishmaniasis", Infect Immun, 66, pp.807~814 (1998)
- Colhone MC, "Effect of hypoxia on macrophage infection by Leishmania amazonensis", J Parasitol, 90, pp.510~515 (2004)
- Degrossoli A, "Functional alterations in macrophages after hypoxia selection", Exp Biol Med, 232, pp.88~95 (2007)
- Chang KP, "Human cutaneous leishmania in a mouse macrophage line : propagation and isolation of intracellular parasites", Science, 209, pp.1240~1242 (1980)
- Linares, E, "Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo", J Parasitol, 86, pp.78~82 (2000)
- Tietjen I, "Screening of the Pan-African Natural Product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors", PLoS One, 10, pp.e0121099~ (2015)
- Paydar M, "Evaluation of cytotoxic and chemotherapeutic properties of boldine in breast cancer using in vitro and in vivo models", Drug Des Devel Ther, 8, pp.719~733 (2014)
- Hung J, "Spectroscopic study of antileishmanial drug incubated in the promastigotes of Leishmania mexicana", Spectrochim Acta A Mol Biomol Spectrosc, 59, pp.3177~3183 (2003)
- Mollataghi A, "Anti-acetylcholinesterase, anti-α-glucosidase, anti-leishmanial and anti-fungal activities of chemical constituents of Beilschmiedia species", Fitoterapia, 83, pp.298~302 (2012)
- Morello A, "Trypanocidal effect of boldine and related alkaloids upon several strains of Trypanosoma cruzi", Comp Biochem Physiol Pharmacol Toxicol Endocrinol, 107, pp.367~371 (1994)
- Moreira RRD, "Release of Intermediate Reactive Hydrogen Peroxide by Macrophage Cells Activated by Natural Products", Biol Pharm Bull, 24, pp.201~204 (2001)
- Kreitmair H, "Pharmacological effects of the alkaloid of Peumus boldus molina", Pharmazie, 7, pp.507~511 (1952)